Groww Banking & Financial Services Fund - Direct Plan - Growth vs Nippon India Pharma Fund-Growth Plan-Bonus Option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

The Groww Banking & Financial Services Fund - Direct Plan - Growth appears stronger in terms of star rating with a 4-star rating compared to the 2-star rating of the Nippon India Pharma Fund-Growth Plan-Bonus Option, indicating better overall performance. However, while Groww's fund has a lower AUM of ₹106 Cr, Nippon India's fund boasts significantly higher AUM at ₹9166 Cr, which may suggest greater investor confidence. Additionally, the Nippon India fund offers higher returns over the 1-year and 3-year periods, but it comes with a slightly lower expense ratio at 0.99% compared to Groww's 1.3%. For investors deciding between these two funds, the choice may hinge on whether they prioritize higher returns or a better star rating.

Groww Mutual Fund

Groww Banking & Financial Services Fund - Direct Plan - Growth

Groww Mutual Fund

★★★★★

Equity · Sectoral Fund

Nippon India Mutual Fund

Nippon India Pharma Fund-Growth Plan-Bonus Option

Nippon India Mutual Fund

★★★★★

Equity · Sectoral Fund

Metric Groww Banking & Financ... Nippon India Pharma Fu...
NAV ₹13.59 ₹582.42
Star Rating ★★★★ ★★
Expense Ratio 1.3% 0.99%
AUM ₹106 Cr ₹9,166 Cr
1M Return +5.06% +8.53%
3M Return -0.15% +2.09%
6M Return +9.01% +6.88%
1Y Return +8.99% +11.76%
3Y CAGR — +16.54%
5Y CAGR — +13.76%
Risk Level — —
Fund Manager Anupam Tiwari Sailesh Raj Bhan